Model 1 is crude. Model 2 is further adjusted for age, gender, proteinuria, ACEI/ARB, antilipemic agents, diseases with a relatively large subgroup of patients (diabetic nephropathy, hypertensive neph
Background: Despite the significant morbidity and mortality attributable to cardiovascular disease (CVD), risk stratification remains an important challenge in the chronic kidney disease
Objectives Owing to recent changes in our understanding of the underlying cause of chronic kidney disease (CKD), the importance of lifestyle modification for preventing the progression of kidney dysfu
